New Antitumor Compounds from Benzofuran Derivatives
Author Information
Author(s): Pan Bowen, Wang Tao, Zheng Liangliang, Dong Zhangchao, Liu Lijuan, Liu Xiongwei, Feng Tingting, Zhou Ying, Shi Yang, Margetic Davor
Primary Institution: College of Pharmacy, Guizhou University of Traditional Chinese Medicine
Hypothesis
Can novel benzofuran spiro-pyrrolidine derivatives exhibit significant antitumor activity?
Conclusion
The study successfully synthesized 24 benzofuran spiro-pyrrolidine derivatives, some of which showed better antiproliferative activities against cancer cells than cisplatin.
Supporting Evidence
- Compounds 4b and 4c showed higher antiproliferative activities against HeLa cells than cisplatin.
- Compounds 4e and 4s exhibited better inhibitory activities against CT26 cells than cisplatin.
- The reaction produced derivatives with yields ranging from 74% to 99%.
Takeaway
Scientists made new compounds from benzofuran that might help fight cancer better than some current treatments.
Methodology
The compounds were synthesized using a three-component [3+2] azomethine ylide cycloaddition reaction, and their antitumor activities were evaluated using the MTT method.
Limitations
The study does not address the long-term effects or potential side effects of the new compounds.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website